Literature DB >> 29140428

HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.

Robert Bolt1, Bernadette Foran2, Craig Murdoch1, Daniel W Lambert1, Sally Thomas3, Keith D Hunter1.   

Abstract

Human papillomavirus (HPV) infection is causally related to a subset of oropharyngeal carcinomas (OPC) and is linked to a more favourable prognosis compared to HPV-negative OPC. The mechanisms underlying this effect on prognosis are not fully understood, but interactions with the tumour microenvironment may be pivotal. Here, we investigated the role of the tumour microenvironment in HPV-positive compared to HPV-negative cancer using 2D and 3D modelling of OPC interactions with stromal fibroblasts. HPV-negative, but not HPV-positive, OPC-derived cell lines induced a rapid fibroblast secretory response that supported 2D cancer cell migration and invasion in vitro. Array profiling of this HPV-negative induced fibroblast secretome identified hepatocyte growth factor (HGF) as the principal secreted factor that promoted cancer cell migration. The interaction between HPV-negative cell lines and fibroblasts in 2D was prevented using c-Met (HGF receptor) inhibitors, which further restricted both HPV-negative and positive cell invasion in 3D co-culture models. Furthermore, we discovered a synergistic relationship between HGF and IL-6 in the support of migration that relates JAK activation to HGF responsiveness in HPV-negative lines. In summary, our data show significant differences in the interactions between HPV-positive and HPV-negative OPC cells and stromal fibroblasts. In addition, we, provide in vitro evidence to support the clinical application of c-MET inhibitors in the control of early HPV-negative OPC.
© The Author(s) 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29140428     DOI: 10.1093/carcin/bgx130

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma.

Authors:  Yae Ohata; Maiko Tsuchiya; Hideaki Hirai; Satoshi Yamaguchi; Takumi Akashi; Kei Sakamoto; Akira Yamaguchi; Tohru Ikeda; Kou Kayamori
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

Review 2.  Activities of stromal and immune cells in HPV-related cancers.

Authors:  Marconi Rego Barros; Cristiane Moutinho Lagos de Melo; Maria Luiza Carneiro Moura Gonçalves Rego Barros; Rita de Cássia Pereira de Lima; Antonio Carlos de Freitas; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2018-07-05

3.  Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.

Authors:  Alexander M Knops; Andrew South; Ulrich Rodeck; Ubaldo Martinez-Outschoorn; Larry A Harshyne; Jennifer Johnson; Adam J Luginbuhl; Joseph M Curry
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

Review 4.  Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview.

Authors:  Xiangwan Miao; Beilei Wang; Kaili Chen; Rui Ding; Jichang Wu; Yi Pan; Peilin Ji; Bin Ye; Mingliang Xiang
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

5.  Increased Abundance of Tumour-Associated Neutrophils in HPV-Negative Compared to HPV-Positive Oropharyngeal Squamous Cell Carcinoma Is Mediated by IL-1R Signalling.

Authors:  Sarmad Al-Sahaf; Naeima B Hendawi; Bethany Ollington; Robert Bolt; Penelope D Ottewell; Keith D Hunter; Craig Murdoch
Journal:  Front Oral Health       Date:  2021-02-11

6.  Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness through the Production of Leukemia Inhibitory Factor.

Authors:  Nazanin Vaziri; Laleh Shariati; Ali Zarrabi; Ali Farazmand; Shaghayegh Haghjooy Javanmard
Journal:  Life (Basel)       Date:  2021-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.